New Alliance Between Singapore’s A*Star and France’s Pasteur Institute Aims to Combat Rising Infectious Diseases
2024-11-12
Author: Li
Overview of the Partnership
In a significant move to tackle the growing threat of infectious diseases in the Asia-Pacific region, the A*Star Infectious Diseases Labs have entered into a groundbreaking partnership with France’s renowned Pasteur Institute.
Memorandum of Understanding (MOU)
On November 12, the two institutions signed a memorandum of understanding (MOU) aimed at addressing the urgent health crises posed by tropical infectious diseases.
Significance of the Collaboration
The Pasteur Institute, established in 1887, is a prestigious non-profit foundation that focuses on the study of microorganisms and various diseases, and is part of the extensive Pasteur Network.
Urgent Health Crises in Southeast Asia
Southeast Asia and the Western Pacific are identified by the World Health Organization as among the most affected regions for dengue, with over half a million cases reported.
The Role of A*Star and Pasteur Institute
The A*Star IDL and the Pasteur Institute are currently collaborating on several initiatives, including studies into antimicrobial resistance.
The Interplay Between Infection and Aging
Professor Ng acknowledged the mutual benefits of this partnership, stating that this collaboration will allow both institutions to share expertise.
Previous Treaties and Bilateral Ties
This agreement follows eight other significant treaties signed in October 2023, covering diverse fields, under the France-Singapore Joint Committee on Science and Innovation.
Conclusion
With this alliance, both institutions' efforts are set to pave the path towards a healthier, more resilient future amid escalating health threats.